A report from the Congressional Budget Office (CBO) assesses trends in spending for prescription drug research and development (R&D) and the introduction of new prescription drugs. CBO also examines factors that determine how much drug companies spend on R&D.
The report can be obtained at https://www.cbo.gov/system/files/2021-04/57025-Rx-RnD.pdf